This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Prognosis

Authoring team

  • 3 in 20 (15%) people diagnosed with gallbladder cancer in England survive their disease for ten years or more (2009-2013)

  • more than 3 in 20 (17%) people diagnosed with gallbladder cancer in England survive their disease for five years or more (2009-2013)

  • more than 4 in 10 (43%) people diagnosed with gallbladder cancer in England survive their disease for one year or more (2009-2013)

  • gallbladder cancer 10-year survival in England is similar in men and women (2009-2013)

  • gallbladder cancer survival in England is highest for adults diagnosed aged under 50 years old (2009-2013)

  • around 4 in 10 people in England diagnosed with gallbladder cancer aged 15-49 survive their disease for five years or more, compared with more than a tenth of people diagnosed aged 70-89 (2009-2013)

Five-year survival for gallbladder cancer is highest in the youngest men and women and decreases with increasing age. Five-year net survival in men ranges from 41% in 15-49 year olds to 15% in 70-89 year-olds for patients diagnosed with gallbladder cancer in England during 2009-2013. In women, five-year survival ranges from 37% to 10% in the same age groups

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.